Igf 1 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurons expressing the insulin-like growth factor 1 receptor (IGF1R) represent a critical population for neuronal survival, development, and function throughout the lifespan. IGF1R is a receptor tyrosine kinase that binds insulin-like growth factor 1 (IGF-1) with high affinity, as well as IGF-2 and insulin at lower affinity [1]. These neurons are widely distributed in the brain and play essential roles in neuroprotection, synaptic plasticity, metabolism, and myelination. The IGF-1 system has emerged as a major therapeutic target for neurodegenerative diseases, particularly Alzheimer's disease and ALS.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000197 | sensory receptor cell |
The IGF1R gene is located on chromosome 15q26.3 in humans and encodes a 1,367-amino acid receptor precursor that is cleaved to form the mature heterotetrameric receptor [2]. The receptor consists of:
IGF1R binds multiple ligands with different affinities:
| Ligand | Affinity | Primary Role |
|---|---|---|
| IGF-1 | Highest | Neuroprotection, development |
| IGF-2 | High | Fetal development |
| Insulin | Low | Metabolic regulation |
IGF1R activates multiple intracellular cascades:
IGF1R-expressing neurons are found throughout the CNS:
| Brain Region | Expression Level | Function |
|---|---|---|
| Cortex | High | Synaptic plasticity |
| Hippocampus | High | Memory, neuroprotection |
| Cerebellum | High | Motor learning |
| Brainstem | Moderate | Various functions |
| Spinal Cord | Moderate | Motor neuron function |
| Hypothalamus | Moderate | Metabolic control |
IGF1R neurons are protected against various insults:
In the cortex and hippocampus:
IGF-1 promotes oligodendrocyte function:
In the hypothalamus:
IGF1R dysfunction is central to Alzheimer's disease pathogenesis:
IGF-1 Signaling Deficit:
Amyloid Relationship:
Therapeutic Strategies:
IGF-1 is a major therapeutic target in ALS:
Motor Neuron Protection:
Therapeutic Approaches:
IGF-1 may be beneficial in Parkinson's disease:
IGF-1 is neuroprotective after injury:
Clinical Use:
Investigational:
Side Effects:
Delivery:
The study of Igf 1 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bondy, C.A., & Cheng, C.M. (2004). Signaling by insulin-like growth factor 1 in brain. European Journal of Pharmacology, 490(1-3), 25-31. 2004. ↩︎
Torres-Aleman, I. (2010). Toward a comprehensive therapy for Alzheimer's disease. CNS Drugs, 24(4), 289-301. 2010. ↩︎
Carro, E., et al. (2002). IGF-1 and Alzheimer's disease: where do we stand? Journal of Alzheimer's Disease, 4(6), 463-474. 2002. ↩︎
Lai, E.C., et al. (1997). Effect of recombinant human insulin-like growth factor-I on progression of ALS. Neurology, 49(6), 1621-1630. 1997. ↩︎